BioteQ Receives Contract for Selenium Removal Pilot

VANCOUVER, BC – BioteQ Environmental Technologies, Inc. (TSX-V : BQE), a leader in the treatment of mine waters, has secured a contract with a Canadian resource company for a pilot scale demonstration and evaluation of its Selen-IX™ technology to remove selenium from mine impacted water. The pilot follows a successful laboratory campaign completed earlier in the year and will utilize BioteQ’s existing mobile Selen-IX™ pilot plant. The objectives of the pilot campaign will be to: demonstrate selenium removal to reach discharge targets on a continuous basis, generate design criteria for a full scale plant, and develop a preliminary capital and operating cost estimate. The pilot campaign is expected to be completed by the end of this year and results will be reviewed with the customer in early 2017 to determine the advancement of the project. The total value of the contract is comparable to past pilot campaigns.

BioteQ is also continuing its applications to patent its selenium removal process. Reviews with international examiners were completed earlier this year and the company received positive responses. The national phases of the application process will begin over the next several quarters.

David Kratochvil, President & Chief Executive Officer at BioteQ commented, “This new pilot contract will be our fourth Selen-IX™ campaign which builds on the success of previous pilot campaigns and demonstrates the increasing awareness of the industry and regulatory agencies about Selen-IX™ and its competitive advantages compared to other treatment processes. It is also a reflection of the growing market for selenium treatment due to stringent and tightening regulations across North America.”

BioteQ Corporate Profile
BioteQ is a service provider that specializes in treating mining wastewater and specific hydrometallurgical streams with the focus on reducing Life Cycle Costs while achieving compliance and introducing sustainability into water management. We have extensive expertise and operations experience in sulphide precipitation, ion exchange, alkali/lime neutralization and SART process technologies. Over the past decade, BioteQ has designed and commissioned plants at mine sites for leading organizations including Glencore Canada, Freeport-McMoRan, Jiangxi Copper and the US EPA and is currently operating six plants under long-term contracts. These plants remove dissolved metals and sulphate to well below the required regulatory discharge limits while reducing or eliminating the production of waste sludge and/or recovering valuable metals from waste streams for sale which reduces the life cycle cost of water treatment. BioteQ is headquartered in Vancouver, Canada and trades on the TSX Venture Exchange under the symbol BQE. Please visit our website at for additional information.


The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release.

Certain information contained herein may not be based on historical fact and therefore constitutes “forward-looking information” under applicable Canadian securities legislation. This includes without limitation statements containing the words “plan”, “expect”, “project”, “estimate”, “intend”, “believe”, “anticipate”, “may”, “will” and other similar words or expressions. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks, uncertainties and other factors that may cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s dependence on key personnel and contracts, uncertainty with respect to the profitability of the Company’s technologies, competition, technology risk, the Company’s ability to protect its intellectual property and proprietary information, fluctuations in commodity prices, currency risk, environmental regulation and the Company’s ability to manage growth and other factors described in the Company’s filings with the Canadian securities regulators at (including without limitation the factors described in the section entitled “Risks and Uncertainties” in the Company’s MD&A for the year ended December 31, 2015). Given these risks and uncertainties, the reader is cautioned not to place undue reliance on forward-looking statements. All forward-looking information contained herein is based on management’s current expectations and the Company undertakes no obligation to revise or update such forward-looking information to reflect subsequent events or circumstances, except as required by law.